ReP USP - Resultado da busca

Filtros : "Indexado no SCOPUS" "SAIA, RAFAEL SIMONE" "Financiamento CNPq" Removido: "Cuccovia, Iolanda Midea" Limpar

Filtros

USP affiliated authors
- giusti, humberto (2)
- saia, rafael simone (2)
- basile filho, anibal (1)
- martins, maria auxiliadora (1)
- ribeiro, aline barbosa (1)

Artigo de periodico
Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection (2021)
Saia, Rafael Simone; Giusti, Humberto; Silva, Fábio Luis da; Pedroso, Karina de Jesus Bonicenha; Martins, Maria Auxiliadora; Morejón, Karen Mirna Loro; Degiovani, Augusto Marcussi; Cadelca, Márcia Regina; Basile-Filho, Anibal
Source: International Journal of Infectious Diseases. Unidade: FMRP
Subjects: CÉLULAS EPITELIAIS, INTESTINOS, CITOCINAS, INFLAMAÇÃO, COVID-19, INTERLEUCINA 6
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAIA, Rafael Simone et al. Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection. International Journal of Infectious Diseases, v. 113, p. 82-86, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ijid.2021.09.051. Acesso em: 03 nov. 2024.
APA
Saia, R. S., Giusti, H., Silva, F. L. da, Pedroso, K. de J. B., Martins, M. A., Morejón, K. M. L., et al. (2021). Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection. International Journal of Infectious Diseases, 113, 82-86. doi:10.1016/j.ijid.2021.09.051
NLM
Saia RS, Giusti H, Silva FL da, Pedroso K de JB, Martins MA, Morejón KML, Degiovani AM, Cadelca MR, Basile-Filho A. Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection [Internet]. International Journal of Infectious Diseases. 2021 ; 113 82-86.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.ijid.2021.09.051
Vancouver
Saia RS, Giusti H, Silva FL da, Pedroso K de JB, Martins MA, Morejón KML, Degiovani AM, Cadelca MR, Basile-Filho A. Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection [Internet]. International Journal of Infectious Diseases. 2021 ; 113 82-86.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1016/j.ijid.2021.09.051
Artigo de periodico
Cholecystokinin modulates the mucosal inflammatory response and prevents the lipopolysaccharide-induced intestinal epithelial barrier dysfunction (2020)
Saia, Rafael Simone; Ribeiro, Aline Barbosa ; Giusti, Humberto
Source: Shock. Unidade: FMRP
Subjects: COLECISTOCININA, ENTEROPATIAS, MUCOSA INTESTINAL, LIPOPOLISSACARÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAIA, Rafael Simone e RIBEIRO, Aline Barbosa e GIUSTI, Humberto. Cholecystokinin modulates the mucosal inflammatory response and prevents the lipopolysaccharide-induced intestinal epithelial barrier dysfunction. Shock, v. 53, n. 2, p. 242-251, 2020Tradução . . Disponível em: https://doi.org/10.1097/SHK.0000000000001355. Acesso em: 03 nov. 2024.
APA
Saia, R. S., Ribeiro, A. B., & Giusti, H. (2020). Cholecystokinin modulates the mucosal inflammatory response and prevents the lipopolysaccharide-induced intestinal epithelial barrier dysfunction. Shock, 53( 2), 242-251. doi:10.1097/SHK.0000000000001355
NLM
Saia RS, Ribeiro AB, Giusti H. Cholecystokinin modulates the mucosal inflammatory response and prevents the lipopolysaccharide-induced intestinal epithelial barrier dysfunction [Internet]. Shock. 2020 ; 53( 2): 242-251.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1097/SHK.0000000000001355
Vancouver
Saia RS, Ribeiro AB, Giusti H. Cholecystokinin modulates the mucosal inflammatory response and prevents the lipopolysaccharide-induced intestinal epithelial barrier dysfunction [Internet]. Shock. 2020 ; 53( 2): 242-251.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1097/SHK.0000000000001355

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024